Atrial Fibrillation Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Atrial Fibrillation Market to 2027 - Global Analysis and Forecasts by Treatment Type (Non-pharmacological and Pharmacological); End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Catheterization Laboratories) and Geography

Report Code: TIPRE00003531 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Atrial fibrillation is arrhythmias that refers to an irregular heart rhythm of the upper chamber of the heart i.e. erratically change of normal sequence electrical impulses. Atrial fibrillation is treated with medications by slowing the heart rate to the rhythm control stage. Technical development in the field of surgical catheter ablation along with rising occurrence of disease due to changes lifestyle habits like drinking and smoking will drive the growth of global atrial fibrillation device market in forecast period.

MARKET DYNAMICS
The atrial fibrillation market is anticipated to grow in the forecast period owing to driving factors such as rise in the prevalence of obesity and hypertension in elderly population, reduced mortality rate and favorable outcomes of the atrial fibrillation devices. However, the catheter related complications and high cost of minimally invasive ablation procedures eventually hinders the market growth.

MARKET SCOPE
The "Global Atrial Fibrillation Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of atrial fibrillation market with detailed market segmentation by treatment type, end user and geography. The global atrial fibrillation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading atrial fibrillation market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global atrial fibrillation market is segmented on the basis of treatment type and end user. Based on treatment type, the market is segmented as non-pharmacological and pharmacological. The atrial fibrillation market, based on end user is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global atrial fibrillation market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The atrial fibrillation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting atrial fibrillation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the atrial fibrillation market in these regions.

MARKET PLAYERS
The reports cover key developments in the atrial fibrillation Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from atrial fibrillation Market are anticipated to lucrative growth opportunities in the future with the rising demand for atrial fibrillation in the global market. Below mentioned is the list of few companies engaged in the atrial fibrillation market.

The report also includes the profiles of key atrial fibrillation market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AtriCure Inc.
  • Biosense Webster Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol- Myers Squibb Corporation
  • Cardio Focus Inc.
  • Endoscopic Technologies Inc.
  • Sanofi
  • Abbott
  • Johnsons & Johnson Services, Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Atrial Fibrillation Market - By Treatment Type
1.3.2 Atrial Fibrillation Market - By End User
1.3.3 Atrial Fibrillation Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ATRIAL FIBRILLATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ATRIAL FIBRILLATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ATRIAL FIBRILLATION MARKET - GLOBAL MARKET ANALYSIS
6.1. ATRIAL FIBRILLATION - GLOBAL MARKET OVERVIEW
6.2. ATRIAL FIBRILLATION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ATRIAL FIBRILLATION MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. NON-PHARMACOLOGICAL
7.3.1. Overview
7.3.2. Non-pharmacological Market Forecast and Analysis
7.3.3. MAZE Surgery Market
7.3.3.1. Overview
7.3.3.2. MAZE Surgery Market Forecast and Analysis
7.3.4. Catheter Ablation Market
7.3.4.1. Overview
7.3.4.2. Catheter Ablation Market Forecast and Analysis
7.3.5. Electric Cardioversion Market
7.3.5.1. Overview
7.3.5.2. Electric Cardioversion Market Forecast and Analysis
7.4. PHARMACOLOGICAL
7.4.1. Overview
7.4.2. Pharmacological Market Forecast and Analysis
7.4.3. Anti-arrhythmic Drugs Market
7.4.3.1. Overview
7.4.3.2. Anti-arrhythmic Drugs Market Forecast and Analysis
7.4.4. Anti-coagulant Drugs Market
7.4.4.1. Overview
7.4.4.2. Anti-coagulant Drugs Market Forecast and Analysis
8. ATRIAL FIBRILLATION MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. AMBULATORY SURGICAL CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
8.5. CARDIAC CATHETERIZATION LABORATORIES
8.5.1. Overview
8.5.2. Cardiac Catheterization Laboratories Market Forecast and Analysis
9. ATRIAL FIBRILLATION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Atrial Fibrillation Market Overview
9.1.2 North America Atrial Fibrillation Market Forecasts and Analysis
9.1.3 North America Atrial Fibrillation Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Atrial Fibrillation Market Forecasts and Analysis - By End User
9.1.5 North America Atrial Fibrillation Market Forecasts and Analysis - By Countries
9.1.5.1 United States Atrial Fibrillation Market
9.1.5.1.1 United States Atrial Fibrillation Market by Treatment Type
9.1.5.1.2 United States Atrial Fibrillation Market by End User
9.1.5.2 Canada Atrial Fibrillation Market
9.1.5.2.1 Canada Atrial Fibrillation Market by Treatment Type
9.1.5.2.2 Canada Atrial Fibrillation Market by End User
9.1.5.3 Mexico Atrial Fibrillation Market
9.1.5.3.1 Mexico Atrial Fibrillation Market by Treatment Type
9.1.5.3.2 Mexico Atrial Fibrillation Market by End User
9.2. EUROPE
9.2.1 Europe Atrial Fibrillation Market Overview
9.2.2 Europe Atrial Fibrillation Market Forecasts and Analysis
9.2.3 Europe Atrial Fibrillation Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Atrial Fibrillation Market Forecasts and Analysis - By End User
9.2.5 Europe Atrial Fibrillation Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Atrial Fibrillation Market
9.2.5.1.1 Germany Atrial Fibrillation Market by Treatment Type
9.2.5.1.2 Germany Atrial Fibrillation Market by End User
9.2.5.2 France Atrial Fibrillation Market
9.2.5.2.1 France Atrial Fibrillation Market by Treatment Type
9.2.5.2.2 France Atrial Fibrillation Market by End User
9.2.5.3 Italy Atrial Fibrillation Market
9.2.5.3.1 Italy Atrial Fibrillation Market by Treatment Type
9.2.5.3.2 Italy Atrial Fibrillation Market by End User
9.2.5.4 Spain Atrial Fibrillation Market
9.2.5.4.1 Spain Atrial Fibrillation Market by Treatment Type
9.2.5.4.2 Spain Atrial Fibrillation Market by End User
9.2.5.5 United Kingdom Atrial Fibrillation Market
9.2.5.5.1 United Kingdom Atrial Fibrillation Market by Treatment Type
9.2.5.5.2 United Kingdom Atrial Fibrillation Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Atrial Fibrillation Market Overview
9.3.2 Asia-Pacific Atrial Fibrillation Market Forecasts and Analysis
9.3.3 Asia-Pacific Atrial Fibrillation Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Atrial Fibrillation Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Atrial Fibrillation Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Atrial Fibrillation Market
9.3.5.1.1 Australia Atrial Fibrillation Market by Treatment Type
9.3.5.1.2 Australia Atrial Fibrillation Market by End User
9.3.5.2 China Atrial Fibrillation Market
9.3.5.2.1 China Atrial Fibrillation Market by Treatment Type
9.3.5.2.2 China Atrial Fibrillation Market by End User
9.3.5.3 India Atrial Fibrillation Market
9.3.5.3.1 India Atrial Fibrillation Market by Treatment Type
9.3.5.3.2 India Atrial Fibrillation Market by End User
9.3.5.4 Japan Atrial Fibrillation Market
9.3.5.4.1 Japan Atrial Fibrillation Market by Treatment Type
9.3.5.4.2 Japan Atrial Fibrillation Market by End User
9.3.5.5 South Korea Atrial Fibrillation Market
9.3.5.5.1 South Korea Atrial Fibrillation Market by Treatment Type
9.3.5.5.2 South Korea Atrial Fibrillation Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Atrial Fibrillation Market Overview
9.4.2 Middle East and Africa Atrial Fibrillation Market Forecasts and Analysis
9.4.3 Middle East and Africa Atrial Fibrillation Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Atrial Fibrillation Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Atrial Fibrillation Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Atrial Fibrillation Market
9.4.5.1.1 South Africa Atrial Fibrillation Market by Treatment Type
9.4.5.1.2 South Africa Atrial Fibrillation Market by End User
9.4.5.2 Saudi Arabia Atrial Fibrillation Market
9.4.5.2.1 Saudi Arabia Atrial Fibrillation Market by Treatment Type
9.4.5.2.2 Saudi Arabia Atrial Fibrillation Market by End User
9.4.5.3 U.A.E Atrial Fibrillation Market
9.4.5.3.1 U.A.E Atrial Fibrillation Market by Treatment Type
9.4.5.3.2 U.A.E Atrial Fibrillation Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Atrial Fibrillation Market Overview
9.5.2 South and Central America Atrial Fibrillation Market Forecasts and Analysis
9.5.3 South and Central America Atrial Fibrillation Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Atrial Fibrillation Market Forecasts and Analysis - By End User
9.5.5 South and Central America Atrial Fibrillation Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Atrial Fibrillation Market
9.5.5.1.1 Brazil Atrial Fibrillation Market by Treatment Type
9.5.5.1.2 Brazil Atrial Fibrillation Market by End User
9.5.5.2 Argentina Atrial Fibrillation Market
9.5.5.2.1 Argentina Atrial Fibrillation Market by Treatment Type
9.5.5.2.2 Argentina Atrial Fibrillation Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ATRIAL FIBRILLATION MARKET, KEY COMPANY PROFILES
11.1. ATRICURE INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BIOSENSE WEBSTER INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BOEHRINGER INGELHEIM GMBH
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BOSTON SCIENTIFIC CORPORATION
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BRISTOL MYERS SQUIBB CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. CARDIO FOCUS INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ENDOSCOPIC TECHNOLOGIES INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SANOFI
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ABBOTT
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. JOHNSONS & JOHNSON SERVICES, LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. AtriCure Inc.
2. Biosense Webster Inc.
3. Boehringer Ingelheim GmbH
4. Boston Scientific Corporation
5. Bristol- Myers Squibb Corporation
6. Cardio Focus Inc.
7. Endoscopic Technologies Inc.
8. Sanofi
9. Abbott
10. Johnsons & Johnson Services, Ltd.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book